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National Health and Nutritional Examination Survey among those with depression 
or hypertension. Methods: We built a logistic regression model using a sample of 
727 respondents aged 0-18 between 2005 and 2012. Results: Out of 727 subjects, 
49.2% were female, 50.1% were male, 11.5% were between the ages of 0-5, 37.8% 
between the ages of 6-10, 26% between the ages of 11-15, 24.5% between the ages 
of 16-18, 28.7% were White, 71.3% were non-White,16.4% were obese and 3.6% had 
hypertension. Obesity and hypertension are significant predictors of depression. 
Children who are obese are about 2.9 times more likely (p= 0.005) to be depressed 
than children who are not obese, and children who suffer from hypertension are 
approximately 4.6 times more likely (p< 0.001) to experience depression than those 
who do not have hypertension. Other significant predictors of depression in children 
are gender (p< 0.001; OR= 0.486) and family size (p= 0.06; OR= 0.673). ConClusions: 
Obesity and hypertension are associated with depression after controlling for other 
factors. This finding has important implications for depression management in 
children. It brings into focus the maintenance of a healthy body mass index (BMI) 
in mitigating depression.
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objeCtives: To investigate the association between anxiety and comorbid obesity 
and hypertension in US children over a 8-year period using data from the National 
Health and Nutritional Examination Survey among those with anxiety or hyper-
tension. Methods: We built a logistic regression model using a sample of 717 
respondents aged 0-18 between 2005 and 2012. Results: Out of 717 subjects, 49.2% 
were female, 50.1% were male, 11.5% were between the ages of 0-5, 37.8% between 
the ages of 6-10, 26% between the ages of 11-15, 24.5% between the ages of 16-18, 
28.7% were White, 71.3% were non-White,16.4% were obese and 3.6% had hyper-
tension. Obesity is a significant predictor of anxiety. Obese children are about 2.1 
times more likely (p= 0.0002) to suffer from anxiety compared with children who 
are not obese. A significant association was also found between anxiety and gender 
(p= 0.05; OR= 0.341) and family income (p= 0.06; OR= 1.012). ConClusions: Obesity 
predicts the prevalence of anxiety in children. The implication is that maintaining a 
healthy body mass index (BMI) in children could significantly reduce the prevalence 
of anxiety in children.
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bACkgRound & objeCtives: Accurate identification of major malformation cases 
from administrative databases is crucial for perinatal epidemiology. In Quebec, most 
of major malformations are detected in hospital, however administrative databases 
capture diagnoses data from both hospitals and other medical facilities. We aimed to 
compare the prevalence of major congenital malformations identified from admin-
istrative databases diagnostic codes (ICD-9 and ICD-10) with 2 definitions: diagnoses 
made in hospital only vs. diagnoses made in hospital and other medical facilities. 
We further evaluated the impact of using each definition to quantify the associa-
tion between maternal use of asthma controller medications and the prevalence of 
major malformations at birth and during the first year of life. Methods: A cohort 
of pregnancies from asthmatic women between 1990 and 2010 was formed through 
the linkage of administrative databases from Quebec. We calculated the prevalence 
of major malformations identified in the 1st year of life of the newborn using the 2 
case definitions. We also calculated the crude odds ratio (OR) of major malforma-
tions associated with maternal use of inhaled corticosteroids (ICS) and long-acting 
beta2-agonists (LABA) in the 1
st trimester of pregnancy. Results: From 30655 preg-
nancies, 2090 (6.8%) major malformations were identified with hospital diagnostic 
codes only vs. 2748 (9.0%) with hospital and other medical facilities diagnostic codes. 
The OR of major malformations associated with ICS was 1.1 (95%CI: 1.0-1.2) with the 
first and 1.1 (95%CI: 1.0-1.2) with the second case definition. Corresponding results 
were 1.3 (95%CI: 1.0-1.6) and 1.1 (95%CI: 0.9-1.4) for LABA exposure. ConClusions: 
The case definition of congenital malformations had a considerable impact on the 
prevalence of major congenital malformations, but less impact on the associations 
we examined. The percentage of false positive cases when using all medical facili-
ties diagnostic codes in the case definition is unknown and should be the objective 
for future research.
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objeCtives: Survival modeling techniques are increasingly being used as part of 
decision modeling for health economic evaluations. As many models are available, 
it is imperative for researchers to know about the steps in selecting and using the 
most suitable ones. This paper is aimed at proposing a tutorial for the application 
of appropriate survival modeling techniques to estimate transition probabilities, for 
use in model-based economic evaluations, in the absence of individual patient data. 
The use of the proposed tutorial is illustrated based on the final progression-free sur-
vival (PFS) analysis of BOLERO-2 trial in metastatic breast cancer (mBC). Methods: 
An algorithm was adopted from Guyot and colleagues, and was then run in the 
statistical package R to reconstruct individual patient data (IPD), based on the final 
components of the Wilson Cleary Model. Methods: 212 persons with a variety of 
advanced cancer from the McGill University Health Center (MUHC) were evaluated 
using nine patient-reported outcomes and seven direct measures over a course of 
18 months. As an attempt to minimize measurement error, Rasch measurement was 
used to model symptoms, function, general health perceptions (GHP), and overall 
quality of life (QOL) latent constructs. Additionally, biological variables were meas-
ured. The latent QOL construct was then modeled over time using “group-based 
modeling”. Probability of group membership was finally predicted using the differ-
ent biological, symptoms, function, and GHP constructs of the Wilson-Cleary model 
at study entry, which coincided with the time of cancer diagnosis. Results: The 
Rasch QOL model over time resulted in 5 distinct trajectories: a linear increasing 
trajectory representing 26% of the sample, two flat medium and high trajectories 
representing 26 and 17% respectively, a quadratic increasing trajectory representing 
25% of the sample, and a linear decreasing trajectory representing 5% of the sample. 
The latent constructs from the time of diagnosis that statistically significantly pre-
dicted membership in a QOL trajectory were age, sex, cancer type, recalled weight 
loss, CRP, social support, emotional status, and fatigue. ConClusions: Using Rasch, 
group-based trajectory modeling, and linear regression, we were able to discrimi-
nate between relevant QOL subgroups of patients. Most importantly, we were able 
to predict QOL trajectory from the time of diagnosis with advanced cancer. This 
enabled us to make preliminary conclusions about the most important contributors 
to QOL over time, and emphasize the importance in assessing these constructs in 
people with cancer.
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objeCtives: High-dimensional propensity score (HDPS) methods have been used 
in health care claims data in an attempt to control confounding by adjusting for 
a large number of covariates that may be proxies for unobserved factors. We have 
previously shown that PS models are biased with non-linear link functions. We 
conducted a Monte Carlo simulation study to understand whether inclusion of 
covariates that are children of unmeasured confounders and other unmeasured par-
ents of the outcome variable (colliders) may bias the relationship between exposure 
and outcome by estimating mean bias, and standard errors. Methods: We used 
directed acyclic graphs to replicate the causal network of plausible confounding 
scenarios. We simulated a scenario where the outcome variable Y is a function of a 
confounder, C, and another parent, U, but not of exposure X (function of C). Covariate 
Z is a function of parents C and U. All variables had normally distributed random 
errors. We conducted Monte Carlo simulations of the causal network, with varying 
strengths of each of the causal relations, and estimated the effect of X on Y, using 
linear regression models, while adjusting for covariate Z. Results: Correctly speci-
fied models were unbiased. Bias was large in models with X only (bias 1.5 with vari-
able standard errors). There was some reduction in bias in some situations where 
Z was highly correlated with the confounder, C, but increased bias when much of 
the variance in Y was determined by U. ConClusions: Adjustment for colliders 
that are children of unmeasured determinants of the outcome variable, but not of 
the exposure, may also increase bias. This is of great importance in observational 
studies, particularly when using HDPS to adjust for large numbers of variables that 
are not true confounders. Researchers should always use causal knowledge when 
using data to make causal inference.
PRM69
size distoRtion of hyPothesis tests foR two-stAge leAst sQUARes 
Model: whAt the RUle of thUMb cAn’t give yoU?
Shao H., Shi L.
Tulane University, New Orleans, LA, USA
objeCtives: Big data approaches may lead to multiple strong instrumental vari-
ables (IV), significantly improving the performance of two-stage least squares model 
(TSLS). The current rule of thumb for detecting weak IV is based on the goal of 
keeping relative bias of TSLS less than 0.1. With the increasing number of IVs, we 
need to examine the impact of week IV on hypothesis testing. We investigated 
whether or not the rule of thumb can be efficient enough to prevent size distor-
tion of hypothesis testing for TSLS? Methods: We used a Monte Carlo approach 
to create 28 original data sets for different models with the number of IVs varying 
from 3 to 30. For each model, we created 2000 observations and conducted 50,000 
iterations to reach a converged outcome. The relationship between the endogenous 
variable and IVs was carefully adjusted to let the F statistics for the first stage model 
equal 10 (rule of thumb). The mean value of relative bias and percent of false rejec-
tion for each model were recorded and compared across all the models. Results: 
The relative bias of TSLS equaled 0.1 constantly across all the models in the study. 
However, the likelihood of rejecting a true hypothesis increased when the number 
of IVs in the model increased while holding the F statistics for the first stage model 
equal to 10. And this likelihood exceeded 10% when TSLS had 24 IVs and exceeded 
15% when TSLS had 30 IVs. ConClusions: When more IVs were added into the 
TSLS model, the rule of thumb was no longer an efficient guarantee for good per-
formance in hypothesis testing. A more restricted margin for F statistics is needed 
to be explored to improve the rule of thumb, especially when the number of IVs 
could be large in the context of big data.
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objeCtives: To investigate the association between depression and comorbid 
obesity and hypertension in US children over a 8-year period using data from the 
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objeCtives: The purpose of this study was to the assess construct validity of the 
World Health Organization’s Quality of Life-BREF (WHOQOL-BREF) instrument among 
adults with autism. Reliability and floor and ceiling effects of the WHOQOL-BREF 
instrument in this population were also assessed. Methods: A cross-sectional 
online survey (using Qualtrics survey system) of adults with autism enrolled with the 
Interactive Autism Network (IAN) was performed for study purposes. Among adults 
with autism registered with the IAN, those aged 18 years and above and having the 
capacity to self-report with little or no proxy help were identified and targeted for the 
study. The proposed structure of the WHOQOL-BREF instrument was validated using 
confirmatory factor analysis. Convergent and discriminant validity was assessed 
based on relevant item-total correlation. Known-groups validity was tested by com-
paring WHOQOL-BREF scores among group differing in autism severity. Cronbach’s 
alpha was used to assess internal consistency reliability. Floor and ceiling effects were 
determined based on percentage (≥ 15%) of responses with lowest and highest pos-
sible score on the instrument, respectively. Results: The final sample included 262 
adults with autism. Based on the CFA analysis, the second-order hierarchical model of 
WHOQOL-BREF instrument was considered the best fitting model among adults with 
autism (chi-square= 428.00, df= 242; RMSEA= 0.054; CFI= 0.091). Corrected item-total 
correlation suggested good convergent and discriminant validity of the WHOQOL-
BREF instrument. Scores for the physical and psychological domains of the WHOQOL-
BREF varied significantly by autism severity, indicating adequate known-groups 
validity. High internal consistency reliability (Cronbach’s alpha 0.914) was observed. 
The floor and ceiling effect are acceptable with the exception of one item which 
displayed floor effect and six items which displayed ceiling effects. ConClusions: 
Study results indicated that the WHOQOL-BREF is a psychometrically sound instru-
ment to assess quality of life among adults with autism.
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objeCtives: The objective was to examine the content of EQ-5D and SF-6D against 
what individuals with mental health problems perceive to be important to their 
quality of life using rigorous qualitative methods. Methods: We first undertook 
a systematic review of qualitative research undertaken with people with mental 
health problems. This review provided the basis for the topic guide used in semi 
structured in-depth interviews undertaken with 19 people who had a broad range 
of mental health problems at varying levels of severity drawn from primary and 
secondary care services (including mood disorders and psychosis) in the UK. The 
interviews were analysed thematically using framework analysis. Results: A 
framework analysis of 13 qualitative studies revealed six major themes: well-being 
and ill-being; control, autonomy and choice; self-perception; belonging; activity; and 
hope. Despite widening the types and severity of mental health problems studied, 
our interview data fitted well with the themes from the review, any differences 
tended to be within the themes and related to the degree of impact of the themes 
on different levels of severity, chronicity and diagnosis. Physical health was also 
found to be more important amongst the interviewees, so it was added as a seventh 
theme as opposed to a minor sub-theme in the review. ConClusions: The review 
of qualitative research and our own interviews raises important questions about 
the content validity of the EQ-5D and SF-6D in mental health. While well-being and 
ill-being are partly covered by dimensions like ‘depression and anxiety’ and ‘feel-
ing downhearted and low’, this leaves out other important aspects such as control, 
autonomy and choice; self-perception; belonging (to society); and hope.
PRM78
A coMPARison of the Utility of vARiAnts of the chARlson 
coMoRbidity index (cci) in PRedicting PAtient-RePoRted heAlth 
oUtcoMes
Witt E.A.1, Goren A.2
1Kantar Health, Princeton, NJ, USA, 2Kantar Health, New York, NY, USA
objeCtives: The Charlson Comorbidity Index (CCI), although intended to predict 
mortality risk, is widely used as a means of controlling for comorbidities. Charlson et al. 
(2008; CCI2008) added items to better predict resource use and alternatively Quan et al. 
(2011; CCI2011) removed or updated the weighting of comorbidities to reflect modern 
estimates of contributions to mortality risk. The current study assessed the predictive 
utility of these three CCI variants across categories of health outcomes. Methods: 
Data were analyzed from the 2013 U.S. National Health and Wellness Survey (n= 75,000), 
an annual, cross-sectional, general health survey of adults (aged ≥ 18). CCI scores were 
calculated from a weighted sum of self-reported diagnoses. Health outcomes included: 
health-related quality of life measured via the SF-36v2 (mental and physical health 
status, and health utilities); Work Productivity and Activity Impairment (WPAI-GH) 
questionnaire-based measures; and resource use (visits to the emergency room, 
hospital, and traditional providers in the last 6 months). CCI scores were correlated 
with health outcomes (Pearson correlations for HRQoL, Spearman’s rho for WPAI-GH 
and resource use). Results: All correlations were significant, p< .001, with higher 
CCI scores associated with worse outcomes. CCI, CCI2008, and CCI2011 correlations 
ranged from lows of -.06, -.20, and -.07, respectively (with mental health status), to 
-.34, -.37, and -.30 (with physical health status), .27, .36, and .24 (with activity impair-
ment), and .33, .39, and .25 (with provider visits). ConClusions: Across all outcomes, 
CCI2008 exhibited the strongest correlations, with the original CCI exhibiting slightly 
higher correlations than CCI2011 in all but two cases. The utility of the CCI depends 
on variance explained in the outcomes plus the anticipated independence of included 
comorbidities vis-à-vis predictors of interest in multivariable models.
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PFS analysis of BOLERO-2 trial. Afterwards, we fitted parametric models to the recon-
structed IPD in the statistical package Stata. Both statistical and graphical tests 
were conducted to verify the relative and absolute validity of the findings. Finally, 
the equations for transition probabilities were derived using the general equation 
for transition probabilities used in model-based economic evaluations, and the 
parameters were estimated from fitted distributions. Results: The results of the 
application of the tutorial suggest that the log-logistic model best fits the recon-
structed data from the latest published KM curves of the BOLERO-2 trial. Results 
from the regression analyses were confirmed graphically. An equation for transition 
probabilities was obtained for each arm of the BOLERO-2 trial. ConClusions: In 
this paper, a tutorial was proposed and used to estimate the transition probabilities 
for model-based economic evaluation, based on the results of the final PFS analy-
sis of the BOLERO-2 trial in mBC. These results can serve as a basis for any model 
(Markov) that needs the parameterization of transition probabilities, and only has 
summary Kaplan-Meier plots available.
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objeCtives: Increasingly, economic evaluations of progressive diseases have 
adopted the approach of partitioned survival analysis. In three state cancer mod-
els (pre-progression, post-progression and death) the proportion of patients in each 
state are often obtained from survival functions for progression free (PFS) and over-
all survival (OS). The proportion in the pre-progression state is estimated from the 
PFS curve and the proportion in the post-progression state is the difference between 
OS and PFS. Based on simulated data reflecting the results from recent randomized 
clinical trials, this study explored the accuracy of this method. Methods: Three 
clinical scenarios were considered based on varying OS. Clinical trial data sets were 
simulated for a standard and a novel treatment assuming substantive benefit with 
the new treatment in terms of slowing progression but no impact of treatment on 
mortality rates within health states. Costs and utility values for each state were 
assumed and represent plausible values. Analysis identified the difference between 
actual results based on complete follow up and results based on curtailed follow up 
of various durations using both traditional Markov modelling and partitioned sur-
vival analysis. Results: In the moderate survival scenario (median OS ~12 months), 
the ICUR for the new treatment based on the raw simulated data was $119,600. 
With trial follow up of 9 months the ICUR for new treatment was $120,600 with 
Markov modelling and $87,500 with partitioned survival analysis. With 18 months 
follow up, the figures were $122,500 and $103,000 respectively. Results with different 
durations of follow up found a consistent pattern as did results for both the short 
and long term survival scenarios. ConClusions: Analyses based on partitioned 
survival analysis have an inherent bias in favour of treatments which impact disease 
progression, not within health state mortality. They should not be considered an 
appropriate basis to facilitate reimbursement decisions.
ReseARch on Methods – Patient-Reported outcomes studies
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objeCtives: This study evaluated the psychometric properties of the Brief Pain 
Inventory-Short Form (BPI-SF) in patients with moderate-to-severe systemic lupus 
erythematosus (SLE). Methods: Participants were recruited using a free electronic 
medication-monitoring service. Patients ≥ 18 years who self-reported a physician 
diagnosis of SLE (confirmed by medical record review) and active SLE demonstrated 
by a Systemic Lupus Activity Questionnaire (SLAQ) score of ≥ 11 (0-44 scale) were 
included. BPI-SF and SF-36 were administered in electronic format at baseline, week 
2, and week 12. Psychometric properties of the BPI-SF and items and domains were 
evaluated by standard statistical techniques. Results: A total of 122 patients were 
included. Cronbach’s alpha were > 0.9 for all BPI-SF items. Test-retest reliability of 
the BPI-SF showed a stable correlation for item #7 (Intraclass Correlation Coefficient 
0.79); all other items and domain correlations were > 0.5. The BPI-SF domain and 
global scores were moderately positively correlated to the SLAQ score (all correlations 
r> 0.4), but negatively correlated to the SF-36 Bodily Pain domain (r< -0.6). The BPI-SF 
domain and global scores were moderately negatively correlated to the SF-36 Physical 
Function domain and Physical Component scores, with low correlations between 
the pain severity domain and SF-36 Mental Component scores (r= -0.16). The BPI-SF 
item #3 (worst pain) was moderately positively correlated to the SLAQ score (r= 0.49). 
Patients who self-reported inactive or less active disease activity (SLAQ < 29) scored 
lower on domain and global scores (p< 0.05) and item #3 (p< 0.0001), compared to 
patients who self-reported active disease activity (SLAQ ≥ 29). The findings suggested 
all BPI-SF domain scores and item #3 were able to differentiate between patients with 
less severe or more severe pain. ConClusions: Assessment of pain intensity, as 
measured by the BPI-SF, demonstrated validity and reliability in a sample of patients 
with SLE and may be used as a patient-reported outcome tool in clinical trials.
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